Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
出版年份 2023 全文链接
标题
Short-term hepatocyte function and portal hypertension outcomes of sofosbuvir/velpatasvir for decompensated hepatitis C-related cirrhosis
作者
关键词
-
出版物
JOURNAL OF GASTROENTEROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-02-02
DOI
10.1007/s00535-023-01963-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosis
- (2022) Yuki Tahata et al. JOURNAL OF GASTROENTEROLOGY
- Cirrhosis regression after SVR with indirect methods of fibrosis analysis: How far is it real?
- (2021) Walnei Fernandes Barbosa et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Real‐world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1‐ and 2‐infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group
- (2021) Toshifumi Tada et al. JOURNAL OF MEDICAL VIROLOGY
- Time‐course changes in liver functional reserve after successful sofosbuvir/velpatasvir treatment in patients with decompensated cirrhosis
- (2021) Masanori Atsukawa et al. HEPATOLOGY RESEARCH
- Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection
- (2021) Eiichi Ogawa et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Baveno VII – Renewing consensus in portal hypertension
- (2021) Roberto de Franchis et al. JOURNAL OF HEPATOLOGY
- A new prognostic algorithm based on stage of cirrhosis and HVPG to improve risk‐stratification after variceal bleeding
- (2020) Vincenzo La Mura et al. HEPATOLOGY
- Long‐term safety and efficacy results in hepatitis C virus genotype 1‒infected patients receiving ombitasvir/paritaprevir/ritonavir + dasabuvir ± ribavirin in the TOPAZ‐I and TOPAZ‐II trials
- (2020) Fred Poordad et al. JOURNAL OF VIRAL HEPATITIS
- Serum Mac-2-binding protein glycosylation isomer predicts esophagogastric varices in cirrhotic patients with chronic hepatitis C virus infection treated with IFN-free direct-acting antiviral agent: M2BPGi levels predict varices in SVR patients
- (2020) Kanako Kikukawa et al. Annals of Hepatology
- Persistence of clinically significant portal hypertension after eradication of HCV in patients with advanced cirrhosis
- (2020) Cristina Díez et al. CLINICAL INFECTIOUS DISEASES
- Japan Society of Hepatology guidelines for the management of hepatitis C virus infection: 2019 update
- (2020) HEPATOLOGY RESEARCH
- Impact of viral eradication by DAAs on the risk of HCC development, prognosis and portal hypertension in HCV‐related compensated cirrhosis patients
- (2020) Yuko Nagaoki et al. HEPATOLOGY RESEARCH
- Clinical outcome and hemodynamic changes following HCV eradication with oral antiviral therapy in patients with clinically significant portal hypertension
- (2020) Sabela Lens et al. JOURNAL OF HEPATOLOGY
- Utility of minimally invasive measurement of hepatic venous pressure gradient via the peripheral antecubital vein
- (2020) Akira Yamamoto et al. GUT
- Real‐world efficacy and safety of 12‐week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infection
- (2020) Yoshinari Takaoka et al. HEPATOLOGY RESEARCH
- Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter study
- (2020) Yuki Tahata et al. JOURNAL OF GASTROENTEROLOGY
- Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity
- (2020) Lisette A.P. Krassenburg et al. JOURNAL OF HEPATOLOGY
- Real‐world impact following initiation of interferon‐free hepatitis C regimens on liver‐related outcomes and all‐cause mortality among patients with compensated cirrhosis
- (2019) Scott A. McDonald et al. JOURNAL OF VIRAL HEPATITIS
- Involvement of portosystemic shunts in impaired improvement of liver function after direct‐acting antiviral therapies in cirrhotic patients with hepatitis C virus
- (2019) Shohei Tsuji et al. HEPATOLOGY RESEARCH
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
- (2018) Paolo Angeli et al. JOURNAL OF HEPATOLOGY
- The presence of multiple NS5A RASs is associated with the outcome of sofosbuvir and ledipasvir therapy in NS5A inhibitor-naïve patients with chronic HCV genotype 1b infection in a real-world cohort
- (2018) R. Kozuka et al. JOURNAL OF VIRAL HEPATITIS
- Short-term histological evaluations after achieving a sustained virologic response to direct-acting antiviral treatment for chronic hepatitis C
- (2018) Masaru Enomoto et al. United European Gastroenterology Journal
- Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial
- (2018) Tetsuo Takehara et al. JOURNAL OF GASTROENTEROLOGY
- Heterogeneous liver uptake of Tc-99m-GSA as quantified through SPECT/CT helps to evaluate the degree of liver fibrosis
- (2018) Kohei Kotani et al. MEDICINE
- Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis
- (2017) Sabela Lens et al. GASTROENTEROLOGY
- Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
- (2017) Pierre Nahon et al. GASTROENTEROLOGY
- Wisteria floribunda agglutinin positive Mac-2-binding protein level increases in patients with acute liver injury
- (2017) Kei Morio et al. JOURNAL OF GASTROENTEROLOGY
- Effect of viral suppression on hepatic venous pressure gradient in hepatitis C with cirrhosis and portal hypertension
- (2017) N. Afdhal et al. JOURNAL OF VIRAL HEPATITIS
- Interferon-free regimens improve portal hypertension and histological necroinflammation in HIV/HCV patients with advanced liver disease
- (2016) P. Schwabl et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
- (2016) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Daclatasvir and asunaprevir treatment improves liver function parameters and reduces liver fibrosis markers in chronic hepatitis C patients
- (2016) Eisuke Miyaki et al. HEPATOLOGY RESEARCH
- Sustained virologic response to interferon-free therapies ameliorates HCV-induced portal hypertension
- (2016) Mattias Mandorfer et al. JOURNAL OF HEPATOLOGY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis
- (2015) Michael P. Curry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Asialoglycoprotein receptor (ASGPR) as target autoantigen in liver autoimmunity: Lost and found
- (2012) Eirini I. Rigopoulou et al. AUTOIMMUNITY REVIEWS
- Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol
- (2012) Thomas Reiberger et al. GUT
- 99mTc-GSA SPECT analysis was clinically useful to evaluate the effect of interferon in a patient with interferon non-responsive chronic hepatitis C
- (2011) Rika Ishii et al. ANNALS OF NUCLEAR MEDICINE
- Histological benefits of virological response to peginterferon alfa-2a monotherapy in patients with hepatitis C and advanced fibrosis or compensated cirrhosis
- (2010) G. T. EVERSON et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started